Both sublingual and supralingual routes of administration are effective in long-term allergen-specific immunotherapy
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F11%3A00002450" target="_blank" >RIV/00023001:_____/11:00002450 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11140/11:10104202
Výsledek na webu
<a href="http://dx.doi.org/10.2500/aap.2011.32.3423" target="_blank" >http://dx.doi.org/10.2500/aap.2011.32.3423</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2500/aap.2011.32.3423" target="_blank" >10.2500/aap.2011.32.3423</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Both sublingual and supralingual routes of administration are effective in long-term allergen-specific immunotherapy
Popis výsledku v původním jazyce
The aim of this study was to confirm or refute the difference between efficacy of long-term specific immunotherapy (SIT) with standardized allergen vaccine consisting of six grass pollens (oat grass, orchard grass, fescue, rye grass, timothy grass, and rye) administered either by sublingual or by supralingual route. To investigate clinical and immunologic changes, 51 patients of a previous 1-year double-blind, placebo-controlled, randomized study were enrolled in an open randomized study that continuedover the next 3 years. Sublingual or supralingual immunotherapy (SLIT) was performed in the same way, keeping the drops under or on the tongue, respectively, for 1-2 minutes before swallowing them. Data about symptoms scores and rescue medication intakeduring grass pollen seasons, as well as skin-prick test results, levels of specific IgG, and IgE antibodies were collected after each pollen season. It was clearly shown that both routes of administration were effective, leading to a sign
Název v anglickém jazyce
Both sublingual and supralingual routes of administration are effective in long-term allergen-specific immunotherapy
Popis výsledku anglicky
The aim of this study was to confirm or refute the difference between efficacy of long-term specific immunotherapy (SIT) with standardized allergen vaccine consisting of six grass pollens (oat grass, orchard grass, fescue, rye grass, timothy grass, and rye) administered either by sublingual or by supralingual route. To investigate clinical and immunologic changes, 51 patients of a previous 1-year double-blind, placebo-controlled, randomized study were enrolled in an open randomized study that continuedover the next 3 years. Sublingual or supralingual immunotherapy (SLIT) was performed in the same way, keeping the drops under or on the tongue, respectively, for 1-2 minutes before swallowing them. Data about symptoms scores and rescue medication intakeduring grass pollen seasons, as well as skin-prick test results, levels of specific IgG, and IgE antibodies were collected after each pollen season. It was clearly shown that both routes of administration were effective, leading to a sign
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
EC - Imunologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2011
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Allergy and asthma proceedings
ISSN
1088-5412
e-ISSN
—
Svazek periodika
32
Číslo periodika v rámci svazku
2
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
9
Strana od-do
142-150
Kód UT WoS článku
000289321100009
EID výsledku v databázi Scopus
—